Medical Condition News

RSS

Early plasma markers help track the progression of Alzheimer's disease

A Quebec research team has discovered two early plasma markers to detect Alzheimer's disease five years before its onset.

28 Jan 2021

New results challenge the current understanding of medulloblastoma

Scientists at St. Jude Children's Research Hospital and their colleagues have published a detailed account of SJMB03, a clinical trial for pediatric patients with medulloblastoma.

28 Jan 2021

Professor receives NIHCM grant to study effect of COVID-19 on patients with chronic conditions

Alison Cuellar, Professor of Health Administration and Policy and Director of the Center for Health Policy Research and Ethics, has been awarded a grant from the National Institute for Health Care Management (NIHCM) to examine how the COVID-19 pandemic changed health care for patients with chronic conditions.

28 Jan 2021

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

Researchers at the Francis Crick Institute, the UCL Cancer Institute, and the Cancer Research UK Lung Cancer Centre of Excellence have identified genetic changes in tumors which could be used to predict if immunotherapy drugs would be effective in individual patients.

28 Jan 2021

APCO launches first pan-Asia Pacific clinical standards for osteoporosis

The Asia Pacific Consortium on Osteoporosis (APCO) has today launched the first pan-Asia Pacific clinical practice standards for the screening, diagnosis, and management of osteoporosis, targeting a broad range of high-risk groups.

28 Jan 2021

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Doctors are increasingly using genetic signatures to diagnose diseases and determine the best course of care, but using DNA sequencing and other techniques to detect genomic rearrangements remains costly or limited in capabilities.

28 Jan 2021

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2, preventing expression of genes that encode proteins in cells such as resident macrophages in the nose and pulmonary alveoli, and epithelial cells lining the alveoli, all of which are entry points for the virus.

28 Jan 2021

Genetically engineered cartilage delivers anti-inflammatory drug in response to knee activity

Working to develop new treatments for osteoarthritis, researchers at Washington University School of Medicine in St. Louis have genetically engineered cartilage to deliver an anti-inflammatory drug in response to activity similar to the bending of a knee or other motions that put stress on joints.

27 Jan 2021

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Diabetics living in the UK worry about disruption to insulin supplies as a result of Brexit, new research shows.

27 Jan 2021

Miniaturized brush tested as a possible technique for loosening cells from walls of pancreatic cysts

In a potential step forward for early pancreatic cancer diagnosis, a miniaturized brush was successfully tested as a possible technique for loosening cells from the walls of pancreatic cysts.

27 Jan 2021

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

A New York Institute of Technology research team led by Olga V. Savinova, Ph.D., assistant professor of biomedical sciences at New York Institute of Technology College of Osteopathic Medicine, has secured a five-year grant from the National Institutes of Health National Heart, Lung, and Blood Institute.

27 Jan 2021

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

The National Institute of Aging, part of the National Institutes of Health, and the Alzheimer's Drug Discovery Foundation awarded five-year grants of $3.2 million and $1.4 million, respectively, to scientists from Cleveland Clinic Lou Ruvo Center for Brain Health to study the therapeutic potential of the anti-cancer drug lenalidomide in early-stage Alzheimer's disease, known as mild cognitive impairment.

27 Jan 2021

Study uncovers a novel promising target for diabetes treatment

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.

27 Jan 2021

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting was held.

27 Jan 2021

Study describes a safe potential therapeutic tool for liver regeneration

A new study led by researchers at the Center for Regenerative Medicine at Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) now describes a safe new potential therapeutic tool for the recovery of liver function in chronic and acute liver diseases.

27 Jan 2021

Researchers identify foods that cause 90% of food allergies

The United States Department of Agriculture identifies a group of "big eight" foods that causes 90% of food allergies. Among these foods are wheat and peanuts.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

Medical Condition News

Early plasma markers help track the progression of Alzheimer's disease

New results challenge the current understanding of medulloblastoma

Professor receives NIHCM grant to study effect of COVID-19 on patients with chronic conditions

Genetic changes in tumors can help predict the efficacy of immunotherapy drugs

APCO launches first pan-Asia Pacific clinical standards for osteoporosis

Innovative breakthrough promises to diagnose DNA rearrangement mutations

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Genetically engineered cartilage delivers anti-inflammatory drug in response to knee activity

Study: Diabetics worry about disruption to insulin supplies owing to Brexit outcome

Miniaturized brush tested as a possible technique for loosening cells from walls of pancreatic cysts

New York Tech researchers receive NIH grant to improve the understanding of atherosclerosis

Cleveland Clinic receives two grants to study therapeutic potential of anti-cancer drug in Alzheimer's

Study uncovers a novel promising target for diabetes treatment

RENACER: New national hospital network aims to advance research on brain metastases

Study describes a safe potential therapeutic tool for liver regeneration

Researchers identify foods that cause 90% of food allergies

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

New study provides both good and bad news about transient ischemic attacks

Black children have significantly higher rates of shellfish and fish allergies than white children

Inflammation of the brain gray matter decreases nerve-cell activity in mouse model

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News